Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ: BOLT · Real-Time Price · USD

5.53

-0.12 (-2.12%)

At close: Aug 1, 2025, 4:00 PM

5.50

-0.03 (-0.54%)

After-hours: Aug 1, 2025, 4:10 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Novel Immunotherapies	7.88M	Log In	Log In	Log In	Log In
Novel Immunotherapies Growth	37.48%	Log In	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	7.88M	Log In	Log In	Log In	Log In
United States Growth	37.48%	Log In	Log In	Log In	Log In